NAMPT and acute myeloid leukemia: Moreover, the inhibition of nicotinamide phosphoribosyltransferase (NAMPT), a rate-limiting enzyme in the NAD metabolism, demonstrated selective eradication of LSCs in relapsed AML patients (24).